Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 May;60(5):478–488. doi: 10.1136/jnnp.60.5.478

Epidemiology of the dementias: recent developments and new approaches.

C M van Duijn 1
PMCID: PMC486358  PMID: 8778250

Full text

PDF
478

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amouyel P., Vidal O., Launay J. M., Laplanche J. L. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet. 1994 Nov 12;344(8933):1315–1318. doi: 10.1016/s0140-6736(94)90691-2. [DOI] [PubMed] [Google Scholar]
  2. Andersen K., Launer L. J., Ott A., Hoes A. W., Breteler M. M., Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology. 1995 Aug;45(8):1441–1445. doi: 10.1212/wnl.45.8.1441. [DOI] [PubMed] [Google Scholar]
  3. Aronson M. K., Ooi W. L., Geva D. L., Masur D., Blau A., Frishman W. Dementia. Age-dependent incidence, prevalence, and mortality in the old old. Arch Intern Med. 1991 May;151(5):989–992. doi: 10.1001/archinte.151.5.989. [DOI] [PubMed] [Google Scholar]
  4. Bachman D. L., Wolf P. A., Linn R. T., Knoefel J. E., Cobb J. L., Belanger A. J., White L. R., D'Agostino R. B. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993 Mar;43(3 Pt 1):515–519. doi: 10.1212/wnl.43.3_part_1.515. [DOI] [PubMed] [Google Scholar]
  5. Basun H., Grut M., Winblad B., Lannfelt L. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett. 1995 Jan 2;183(1-2):32–34. doi: 10.1016/0304-3940(94)11107-t. [DOI] [PubMed] [Google Scholar]
  6. Beard C. M., Kokman E., Kurland L. T. Rheumatoid arthritis and susceptibility to Alzheimer's disease. Lancet. 1991 Jun 8;337(8754):1426–1426. doi: 10.1016/0140-6736(91)93122-p. [DOI] [PubMed] [Google Scholar]
  7. Beard C. M., Kokmen E., O'Brien P. C., Kurland L. T. Are patients with Alzheimer's disease surviving longer in recent years? Neurology. 1994 Oct;44(10):1869–1871. doi: 10.1212/wnl.44.10.1869. [DOI] [PubMed] [Google Scholar]
  8. Beard C. M., Kokmen E., Offord K. P., Kurland L. T. Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement. Neurology. 1992 Nov;42(11):2063–2068. doi: 10.1212/wnl.42.11.2063. [DOI] [PubMed] [Google Scholar]
  9. Berr C., Borghi E., Rethoré M. O., Lejeune J., Alperovitch A. Absence of familial association between dementia of Alzheimer type and Down syndrome. Am J Med Genet. 1989 Aug;33(4):545–550. doi: 10.1002/ajmg.1320330427. [DOI] [PubMed] [Google Scholar]
  10. Bickel H., Cooper B. Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study. Psychol Med. 1994 Feb;24(1):179–192. doi: 10.1017/s0033291700026945. [DOI] [PubMed] [Google Scholar]
  11. Boothby H., Blizard R., Livingston G., Mann A. H. The Gospel Oak Study stage III: the incidence of dementia. Psychol Med. 1994 Feb;24(1):89–95. doi: 10.1017/s0033291700026866. [DOI] [PubMed] [Google Scholar]
  12. Bots M. L., van Swieten J. C., Breteler M. M., de Jong P. T., van Gijn J., Hofman A., Grobbee D. E. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet. 1993 May 15;341(8855):1232–1237. doi: 10.1016/0140-6736(93)91144-b. [DOI] [PubMed] [Google Scholar]
  13. Breitner J. C., Gau B. A., Welsh K. A., Plassman B. L., McDonald W. M., Helms M. J., Anthony J. C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 1994 Feb;44(2):227–232. doi: 10.1212/wnl.44.2.227. [DOI] [PubMed] [Google Scholar]
  14. Brenner D. E., Kukull W. A., Stergachis A., van Belle G., Bowen J. D., McCormick W. C., Teri L., Larson E. B. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 1994 Aug 1;140(3):262–267. doi: 10.1093/oxfordjournals.aje.a117245. [DOI] [PubMed] [Google Scholar]
  15. Brenner D. E., Kukull W. A., van Belle G., Bowen J. D., McCormick W. C., Teri L., Larson E. B. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology. 1993 Feb;43(2):293–300. doi: 10.1212/wnl.43.2.293. [DOI] [PubMed] [Google Scholar]
  16. Breteler M. M., Claus J. J., van Duijn C. M., Launer L. J., Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev. 1992;14:59–82. doi: 10.1093/oxfordjournals.epirev.a036092. [DOI] [PubMed] [Google Scholar]
  17. Brugg B., Dubreuil Y. L., Huber G., Wollman E. E., Delhaye-Bouchaud N., Mariani J. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3032–3035. doi: 10.1073/pnas.92.7.3032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Candy J. M., McArthur F. K., Oakley A. E., Taylor G. A., Chen C. P., Mountfort S. A., Thompson J. E., Chalker P. R., Bishop H. E., Beyreuther K. Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J Neurol Sci. 1992 Feb;107(2):210–218. doi: 10.1016/0022-510x(92)90291-r. [DOI] [PubMed] [Google Scholar]
  19. Chabriat H., Vahedi K., Iba-Zizen M. T., Joutel A., Nibbio A., Nagy T. G., Krebs M. O., Julien J., Dubois B., Ducrocq X. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995 Oct 7;346(8980):934–939. doi: 10.1016/s0140-6736(95)91557-5. [DOI] [PubMed] [Google Scholar]
  20. Chartier-Harlin M. C., Parfitt M., Legrain S., Pérez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994 Apr;3(4):569–574. doi: 10.1093/hmg/3.4.569. [DOI] [PubMed] [Google Scholar]
  21. Chen J. Y., Stern Y., Sano M., Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol. 1991 Nov;48(11):1141–1143. doi: 10.1001/archneur.1991.00530230049020. [DOI] [PubMed] [Google Scholar]
  22. Chen X., Xia Y., Alford M., DeTeresa R., Hansen L., Klauber M. R., Katzman R., Thal L., Masliah E., Saitoh T. The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease. Ann Neurol. 1995 Oct;38(4):653–658. doi: 10.1002/ana.410380415. [DOI] [PubMed] [Google Scholar]
  23. Cobb J. L., Wolf P. A., Au R., White R., D'Agostino R. B. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology. 1995 Sep;45(9):1707–1712. doi: 10.1212/wnl.45.9.1707. [DOI] [PubMed] [Google Scholar]
  24. Copeland J. R., Davidson I. A., Dewey M. E., Gilmore C., Larkin B. A., McWilliam C., Saunders P. A., Scott A., Sharma V., Sullivan C. Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry. 1992 Aug;161:230–239. doi: 10.1192/bjp.161.2.230. [DOI] [PubMed] [Google Scholar]
  25. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  26. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., Tanzi R. E. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995 Jul;45(7):1323–1328. doi: 10.1212/wnl.45.7.1323. [DOI] [PubMed] [Google Scholar]
  27. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Roses A. D., Pericak-Vance M. A., Small G. W., Haines J. L. The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease. JAMA. 1995 Feb 1;273(5):373–374. [PubMed] [Google Scholar]
  28. Crapper McLachlan D. R., Dalton A. J., Kruck T. P., Bell M. Y., Smith W. L., Kalow W., Andrews D. F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet. 1991 Jun 1;337(8753):1304–1308. doi: 10.1016/0140-6736(91)92978-b. [DOI] [PubMed] [Google Scholar]
  29. Cummings J. L. Dementia: the failing brain. Lancet. 1995 Jun 10;345(8963):1481–1484. doi: 10.1016/s0140-6736(95)91039-5. [DOI] [PubMed] [Google Scholar]
  30. Dash P. K., Moore A. N. Enhanced processing of APP induced by IL-1 beta can be reduced by indomethacin and nordihydroguaiaretic acid. Biochem Biophys Res Commun. 1995 Mar 17;208(2):542–548. doi: 10.1006/bbrc.1995.1372. [DOI] [PubMed] [Google Scholar]
  31. Doll R. Review: Alzheimer's disease and environmental aluminium. Age Ageing. 1993 Mar;22(2):138–153. doi: 10.1093/ageing/22.2.138. [DOI] [PubMed] [Google Scholar]
  32. Edling C., Ekberg K., Ahlborg G., Jr, Alexandersson R., Barregård L., Ekenvall L., Nilsson L., Svensson B. G. Long-term follow up of workers exposed to solvents. Br J Ind Med. 1990 Feb;47(2):75–82. doi: 10.1136/oem.47.2.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Edwardson J. A., Moore P. B., Ferrier I. N., Lilley J. S., Newton G. W., Barker J., Templar J., Day J. P. Effect of silicon on gastrointestinal absorption of aluminium. Lancet. 1993 Jul 24;342(8865):211–212. doi: 10.1016/0140-6736(93)92301-9. [DOI] [PubMed] [Google Scholar]
  34. Ewins D. L., Rossor M. N., Butler J., Roques P. K., Mullan M. J., McGregor A. M. Association between autoimmune thyroid disease and familial Alzheimer's disease. Clin Endocrinol (Oxf) 1991 Jul;35(1):93–96. doi: 10.1111/j.1365-2265.1991.tb03502.x. [DOI] [PubMed] [Google Scholar]
  35. Farrer L. A., Cupples L. A., Connor L., Wolf P. A., Growdon J. H. Association of decreased paternal age and late-onset Alzheimer's disease. An example of genetic imprinting? Arch Neurol. 1991 Jun;48(6):599–604. doi: 10.1001/archneur.1991.00530180051017. [DOI] [PubMed] [Google Scholar]
  36. Farrer L. A., Cupples L. A., van Duijn C. M., Connor-Lacke L., Kiely D. K., Growdon J. H. Rate of progression of Alzheimer's disease is associated with genetic risk. Arch Neurol. 1995 Sep;52(9):918–923. doi: 10.1001/archneur.1995.00540330100021. [DOI] [PubMed] [Google Scholar]
  37. Fasman G. D., Perczel A., Moore C. D. Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates. Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):369–371. doi: 10.1073/pnas.92.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Feskens E. J., Havekes L. M., Kalmijn S., de Knijff P., Launer L. J., Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ. 1994 Nov 5;309(6963):1202–1206. doi: 10.1136/bmj.309.6963.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Forster D. P., Newens A. J., Kay D. W., Edwardson J. A. Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Community Health. 1995 Jun;49(3):253–258. doi: 10.1136/jech.49.3.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Fosmire G. J., Focht S. J., McClearn G. E. Genetic influences on tissue deposition of aluminum in mice. Biol Trace Elem Res. 1993 May-Jun;37(2-3):115–121. doi: 10.1007/BF02783787. [DOI] [PubMed] [Google Scholar]
  41. Fratiglioni L., Ahlbom A., Viitanen M., Winblad B. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol. 1993 Mar;33(3):258–266. doi: 10.1002/ana.410330306. [DOI] [PubMed] [Google Scholar]
  42. Frisoni G. B., Geroldi C., Bianchetti A., Trabucchi M., Govoni S., Franceschini G., Calabresi L. Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's disease. Stroke. 1994 Aug;25(8):1703–1704. doi: 10.1161/01.str.25.8.1703. [DOI] [PubMed] [Google Scholar]
  43. Frisoni G. B., Govoni S., Geroldi C., Bianchetti A., Calabresi L., Franceschini G., Trabucchi M. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol. 1995 May;37(5):596–604. doi: 10.1002/ana.410370509. [DOI] [PubMed] [Google Scholar]
  44. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  45. Haltia M., Viitanen M., Sulkava R., Ala-Hurula V., Poyhonen M., Goldfarb L., Brown P., Levy E., Houlden H., Crook R. Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol. 1994 Sep;36(3):362–367. doi: 10.1002/ana.410360307. [DOI] [PubMed] [Google Scholar]
  46. Harrington C. R., Wischik C. M., McArthur F. K., Taylor G. A., Edwardson J. A., Candy J. M. Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet. 1994 Apr 23;343(8904):993–997. doi: 10.1016/s0140-6736(94)90124-4. [DOI] [PubMed] [Google Scholar]
  47. Hebert L. E., Scherr P. A., Beckett L. A., Albert M. S., Pilgrim D. M., Chown M. J., Funkenstein H. H., Evans D. A. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995 May 3;273(17):1354–1359. [PubMed] [Google Scholar]
  48. Hebert L. E., Scherr P. A., Beckett L. A., Funkenstein H. H., Albert M. S., Chown M. J., Evans D. A. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol. 1992 Feb 15;135(4):347–355. doi: 10.1093/oxfordjournals.aje.a116296. [DOI] [PubMed] [Google Scholar]
  49. Henderson A. S., Easteal S., Jorm A. F., Mackinnon A. J., Korten A. E., Christensen H., Croft L., Jacomb P. A. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet. 1995 Nov 25;346(8987):1387–1390. doi: 10.1016/s0140-6736(95)92405-1. [DOI] [PubMed] [Google Scholar]
  50. Henderson V. W., Paganini-Hill A., Emanuel C. K., Dunn M. E., Buckwalter J. G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 1994 Sep;51(9):896–900. doi: 10.1001/archneur.1994.00540210068014. [DOI] [PubMed] [Google Scholar]
  51. Hendrie H. C., Hall K. S., Hui S., Unverzagt F. W., Yu C. E., Lahiri D. K., Sahota A., Farlow M., Musick B., Class C. A. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol. 1995 Jan;37(1):118–120. doi: 10.1002/ana.410370123. [DOI] [PubMed] [Google Scholar]
  52. Hendrie H. C., Hall K. S., Hui S., Unverzagt F. W., Yu C. E., Lahiri D. K., Sahota A., Farlow M., Musick B., Class C. A. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol. 1995 Jan;37(1):118–120. doi: 10.1002/ana.410370123. [DOI] [PubMed] [Google Scholar]
  53. Hier D. B., Warach J. D., Gorelick P. B., Thomas J. Predictors of survival in clinically diagnosed Alzheimer's disease and multi-infarct dementia. Arch Neurol. 1989 Nov;46(11):1213–1216. doi: 10.1001/archneur.1989.00520470073030. [DOI] [PubMed] [Google Scholar]
  54. Holland A. J., Oliver C. Down's syndrome and the links with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1995 Aug;59(2):111–114. doi: 10.1136/jnnp.59.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Honjo H., Tanaka K., Kashiwagi T., Urabe M., Okada H., Hayashi M., Hayashi K. Senile dementia-Alzheimer's type and estrogen. Horm Metab Res. 1995 Apr;27(4):204–207. doi: 10.1055/s-2007-979941. [DOI] [PubMed] [Google Scholar]
  56. Jacqmin H., Commenges D., Letenneur L., Barberger-Gateau P., Dartigues J. F. Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol. 1994 Jan 1;139(1):48–57. doi: 10.1093/oxfordjournals.aje.a116934. [DOI] [PubMed] [Google Scholar]
  57. Jarvik G. P., Wijsman E. M., Kukull W. A., Schellenberg G. D., Yu C., Larson E. B. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology. 1995 Jun;45(6):1092–1096. doi: 10.1212/wnl.45.6.1092. [DOI] [PubMed] [Google Scholar]
  58. Jones G. M., Sahakian B. J., Levy R., Warburton D. M., Gray J. A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl) 1992;108(4):485–494. doi: 10.1007/BF02247426. [DOI] [PubMed] [Google Scholar]
  59. Jorm A. F. Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias. Eur Arch Psychiatry Clin Neurosci. 1991;240(4-5):218–222. doi: 10.1007/BF02189530. [DOI] [PubMed] [Google Scholar]
  60. Jorm A. F., van Duijn C. M., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Kokmen E., Kondo K., Mortimer J. A., Rocca W. A. Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20 (Suppl 2):S43–S47. doi: 10.1093/ije/20.supplement_2.s43. [DOI] [PubMed] [Google Scholar]
  61. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology. 1993 Jan;43(1):13–20. doi: 10.1212/wnl.43.1_part_1.13. [DOI] [PubMed] [Google Scholar]
  62. Katzman R., Hill L. R., Yu E. S., Wang Z. Y., Booth A., Salmon D. P., Liu W. T., Qu G. Y., Zhang M. The malignancy of dementia. Predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Arch Neurol. 1994 Dec;51(12):1220–1225. doi: 10.1001/archneur.1994.00540240064017. [DOI] [PubMed] [Google Scholar]
  63. Kawahara M., Muramoto K., Kobayashi K., Mori H., Kuroda Y. Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Biochem Biophys Res Commun. 1994 Jan 28;198(2):531–535. doi: 10.1006/bbrc.1994.1078. [DOI] [PubMed] [Google Scholar]
  64. Kennedy A. M., Newman S. K., Frackowiak R. S., Cunningham V. J., Roques P., Stevens J., Neary D., Bruton C. J., Warrington E. K., Rossor M. N. Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. Brain. 1995 Feb;118(Pt 1):185–205. doi: 10.1093/brain/118.1.185. [DOI] [PubMed] [Google Scholar]
  65. Knesevich J. W., Toro F. R., Morris J. C., LaBarge E. Aphasia, family history, and the longitudinal course of senile dementia of the Alzheimer type. Psychiatry Res. 1985 Mar;14(3):255–263. doi: 10.1016/0165-1781(85)90020-4. [DOI] [PubMed] [Google Scholar]
  66. Kokmen E., Beard C. M., O'Brien P. C., Offord K. P., Kurland L. T. Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984) Neurology. 1993 Oct;43(10):1887–1892. doi: 10.1212/wnl.43.10.1887. [DOI] [PubMed] [Google Scholar]
  67. Lampe T. H., Bird T. D., Nochlin D., Nemens E., Risse S. C., Sumi S. M., Koerker R., Leaird B., Wier M., Raskind M. A. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol. 1994 Sep;36(3):368–378. doi: 10.1002/ana.410360308. [DOI] [PubMed] [Google Scholar]
  68. Landsberg J. P., McDonald B., Watt F. Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature. 1992 Nov 5;360(6399):65–68. doi: 10.1038/360065a0. [DOI] [PubMed] [Google Scholar]
  69. Lannfelt L., Lilius L., Nastase M., Viitanen M., Fratiglioni L., Eggertsen G., Berglund L., Angelin B., Linder J., Winblad B. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett. 1994 Mar 14;169(1-2):175–178. doi: 10.1016/0304-3940(94)90384-0. [DOI] [PubMed] [Google Scholar]
  70. Lee P. N. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology. 1994;13(4):131–144. doi: 10.1159/000110372. [DOI] [PubMed] [Google Scholar]
  71. Letenneur L., Commenges D., Dartigues J. F., Barberger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol. 1994 Dec;23(6):1256–1261. doi: 10.1093/ije/23.6.1256. [DOI] [PubMed] [Google Scholar]
  72. Letenneur L., Dartigues J. F., Commenges D., Barberger-Gateau P., Tessier J. F., Orgogozo J. M. Tobacco consumption and cognitive impairment in elderly people. A population-based study. Ann Epidemiol. 1994 Nov;4(6):449–454. doi: 10.1016/1047-2797(94)90004-3. [DOI] [PubMed] [Google Scholar]
  73. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995 Aug 18;269(5226):973–977. doi: 10.1126/science.7638622. [DOI] [PubMed] [Google Scholar]
  74. Li G., Shen Y. C., Li Y. T., Chen C. H., Zhau Y. W., Silverman J. M. A case-control study of Alzheimer's disease in China. Neurology. 1992 Aug;42(8):1481–1488. doi: 10.1212/wnl.42.8.1481. [DOI] [PubMed] [Google Scholar]
  75. Lucca U., Tettamanti M., Forloni G., Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry. 1994 Dec 15;36(12):854–856. doi: 10.1016/0006-3223(94)90598-3. [DOI] [PubMed] [Google Scholar]
  76. Luchins D. J., Cohen D., Hanrahan P., Eisdorfer C., Paveza G., Ashford J. W., Gorelick P., Hirschman R., Freels S., Levy P. Are there clinical differences between familial and nonfamilial Alzheimer's disease? Am J Psychiatry. 1992 Aug;149(8):1023–1027. doi: 10.1176/ajp.149.8.1023. [DOI] [PubMed] [Google Scholar]
  77. Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M. X., Shelanski M., Tycko B., Mayeux R. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995 Feb;37(2):254–259. doi: 10.1002/ana.410370217. [DOI] [PubMed] [Google Scholar]
  78. Mayeux R., Ottman R., Maestre G., Ngai C., Tang M. X., Ginsberg H., Chun M., Tycko B., Shelanski M. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology. 1995 Mar;45(3 Pt 1):555–557. doi: 10.1212/wnl.45.3.555. [DOI] [PubMed] [Google Scholar]
  79. Mayeux R., Ottman R., Tang M. X., Noboa-Bauza L., Marder K., Gurland B., Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol. 1993 May;33(5):494–501. doi: 10.1002/ana.410330513. [DOI] [PubMed] [Google Scholar]
  80. Mendez M. F., Underwood K. L., Zander B. A., Mastri A. R., Sung J. H., Frey W. H., 2nd Risk factors in Alzheimer's disease: a clinicopathologic study. Neurology. 1992 Apr;42(4):770–775. doi: 10.1212/wnl.42.4.770. [DOI] [PubMed] [Google Scholar]
  81. Morens D. M., Grandinetti A., Reed D., White L. R., Ross G. W. Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology. 1995 Jun;45(6):1041–1051. doi: 10.1212/wnl.45.6.1041. [DOI] [PubMed] [Google Scholar]
  82. Morgan K., Lilley J. M., Arie T., Byrne E. J., Jones R., Waite J. Incidence of dementia in a representative British sample. Br J Psychiatry. 1993 Oct;163:467–470. doi: 10.1192/bjp.163.4.467. [DOI] [PubMed] [Google Scholar]
  83. Moritz D. J., Petitti D. B. Association of education with reported age of onset and severity of Alzheimer's disease at presentation: implications for the use of clinical samples. Am J Epidemiol. 1993 Feb 15;137(4):456–462. doi: 10.1093/oxfordjournals.aje.a116694. [DOI] [PubMed] [Google Scholar]
  84. Mortimer J. A., van Duijn C. M., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Rocca W. A. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20 (Suppl 2):S28–S35. doi: 10.1093/ije/20.supplement_2.s28. [DOI] [PubMed] [Google Scholar]
  85. Mölsä P. K., Marttila R. J., Rinne U. K. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand. 1995 Mar;91(3):159–164. doi: 10.1111/j.1600-0404.1995.tb00426.x. [DOI] [PubMed] [Google Scholar]
  86. Newhouse P. A., Potter A., Corwin J., Lenox R. Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology. 1994 Apr;10(2):93–107. doi: 10.1038/npp.1994.11. [DOI] [PubMed] [Google Scholar]
  87. Nilsson L. V. Incidence of severe dementia in an urban sample followed from 70 to 79 years of age. Acta Psychiatr Scand. 1984 Nov;70(5):478–486. doi: 10.1111/j.1600-0447.1984.tb01237.x. [DOI] [PubMed] [Google Scholar]
  88. Nitta A., Katono Y., Itoh A., Hasegawa T., Nabeshima T. Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system. Pharmacol Biochem Behav. 1994 Dec;49(4):807–812. doi: 10.1016/0091-3057(94)90227-5. [DOI] [PubMed] [Google Scholar]
  89. O'Mahony D., Denton J., Templar J., O'Hara M., Day J. P., Murphy S., Walsh J. B., Coakley D. Bone aluminium content in Alzheimer's disease. Dementia. 1995 Mar-Apr;6(2):69–72. doi: 10.1159/000106924. [DOI] [PubMed] [Google Scholar]
  90. Paganini-Hill A., Henderson V. W. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 1994 Aug 1;140(3):256–261. doi: 10.1093/oxfordjournals.aje.a117244. [DOI] [PubMed] [Google Scholar]
  91. Pantoni L., Garcia J. H. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke. 1995 Jul;26(7):1293–1301. doi: 10.1161/01.str.26.7.1293. [DOI] [PubMed] [Google Scholar]
  92. Payami H., Montee K. R., Kaye J. A., Bird T. D., Yu C. E., Wijsman E. M., Schellenberg G. D. Alzheimer's disease, apolipoprotein E4, and gender. JAMA. 1994 May 4;271(17):1316–1317. [PubMed] [Google Scholar]
  93. Paykel E. S., Brayne C., Huppert F. A., Gill C., Barkley C., Gehlhaar E., Beardsall L., Girling D. M., Pollitt P., O'Connor D. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry. 1994 Apr;51(4):325–332. doi: 10.1001/archpsyc.1994.03950040069009. [DOI] [PubMed] [Google Scholar]
  94. Petersen R. C., Smith G. E., Ivnik R. J., Tangalos E. G., Schaid D. J., Thibodeau S. N., Kokmen E., Waring S. C., Kurland L. T. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995 Apr 26;273(16):1274–1278. [PubMed] [Google Scholar]
  95. Plassman B. L., Helms M. J., Welsh K. A., Saunders A. M., Breitner J. C. Smoking, Alzheimer's disease, and confounding with genes. Lancet. 1995 Feb 11;345(8946):387–387. doi: 10.1016/s0140-6736(95)90374-7. [DOI] [PubMed] [Google Scholar]
  96. Prince M., Cullen M., Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology. 1994 Jan;44(1):97–104. doi: 10.1212/wnl.44.1.97. [DOI] [PubMed] [Google Scholar]
  97. Rasmusson D. X., Brandt J., Martin D. B., Folstein M. F. Head injury as a risk factor in Alzheimer's disease. Brain Inj. 1995 Apr;9(3):213–219. doi: 10.3109/02699059509008194. [DOI] [PubMed] [Google Scholar]
  98. Rebeck G. W., Perls T. T., West H. L., Sodhi P., Lipsitz L. A., Hyman B. T. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 1994 Aug;44(8):1513–1516. doi: 10.1212/wnl.44.8.1513. [DOI] [PubMed] [Google Scholar]
  99. Reed T., Carmelli D., Swan G. E., Breitner J. C., Welsh K. A., Jarvik G. P., Deeb S., Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol. 1994 Dec;51(12):1189–1192. doi: 10.1001/archneur.1994.00540240033012. [DOI] [PubMed] [Google Scholar]
  100. Rich J. B., Rasmusson D. X., Folstein M. F., Carson K. A., Kawas C., Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology. 1995 Jan;45(1):51–55. doi: 10.1212/wnl.45.1.51. [DOI] [PubMed] [Google Scholar]
  101. Rifat S. L., Eastwood M. R., McLachlan D. R., Corey P. N. Effect of exposure of miners to aluminium powder. Lancet. 1990 Nov 10;336(8724):1162–1165. doi: 10.1016/0140-6736(90)92775-d. [DOI] [PubMed] [Google Scholar]
  102. Risse S. C., Lampe T. H., Bird T. D., Nochlin D., Sumi S. M., Keenan T., Cubberley L., Peskind E., Raskind M. A. Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord. 1990 Winter;4(4):217–225. doi: 10.1097/00002093-199040400-00003. [DOI] [PubMed] [Google Scholar]
  103. Roberts G. W., Gentleman S. M., Lynch A., Murray L., Landon M., Graham D. I. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):419–425. doi: 10.1136/jnnp.57.4.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995 Aug 31;376(6543):775–778. doi: 10.1038/376775a0. [DOI] [PubMed] [Google Scholar]
  105. Rorsman B., Hagnell O., Lanke J. Prevalence and incidence of senile and multi-infarct dementia in the Lundby Study: a comparison between the time periods 1947-1957 and 1957-1972. Neuropsychobiology. 1986;15(3-4):122–129. doi: 10.1159/000118254. [DOI] [PubMed] [Google Scholar]
  106. Sadovnick A. D., Yee I. M., Hirst C. The rate of the Down syndrome among offspring of women with Alzheimer disease. Psychiatr Genet. 1994 Summer;4(2):87–89. doi: 10.1097/00041444-199422000-00004. [DOI] [PubMed] [Google Scholar]
  107. Saitoh T., Xia Y., Chen X., Masliah E., Galasko D., Shults C., Thal L. J., Hansen L. A., Katzman R. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol. 1995 Jan;37(1):110–112. doi: 10.1002/ana.410370120. [DOI] [PubMed] [Google Scholar]
  108. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  109. Scheltens P., Barkhof F., Valk J., Algra P. R., van der Hoop R. G., Nauta J., Wolters E. C. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain. 1992 Jun;115(Pt 3):735–748. doi: 10.1093/brain/115.3.735. [DOI] [PubMed] [Google Scholar]
  110. Schupf N., Kapell D., Lee J. H., Ottman R., Mayeux R. Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet. 1994 Aug 6;344(8919):353–356. doi: 10.1016/s0140-6736(94)91398-6. [DOI] [PubMed] [Google Scholar]
  111. Scott C. W., Fieles A., Sygowski L. A., Caputo C. B. Aggregation of tau protein by aluminum. Brain Res. 1993 Nov 19;628(1-2):77–84. doi: 10.1016/0006-8993(93)90940-o. [DOI] [PubMed] [Google Scholar]
  112. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995 Jun 29;375(6534):754–760. doi: 10.1038/375754a0. [DOI] [PubMed] [Google Scholar]
  113. Shimano H., Ishibashi S., Murase T., Gotohda T., Yamada N., Takaku F., Ohtomo E. Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis. 1989 Oct;79(2-3):257–260. doi: 10.1016/0021-9150(89)90132-9. [DOI] [PubMed] [Google Scholar]
  114. Skoog I. Risk factors for vascular dementia: a review. Dementia. 1994 May-Aug;5(3-4):137–144. doi: 10.1159/000106711. [DOI] [PubMed] [Google Scholar]
  115. Sobel E., Louhija J., Sulkava R., Davanipour Z., Kontula K., Miettinen H., Tikkanen M., Kainulainen K., Tilvis R. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995 May;45(5):903–907. doi: 10.1212/wnl.45.5.903. [DOI] [PubMed] [Google Scholar]
  116. Sorbi S., Nacmias B., Forleo P., Latorraca S., Gobbini I., Bracco L., Piacentini S., Amaducci L. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 1994 Aug 15;177(1-2):100–102. doi: 10.1016/0304-3940(94)90054-x. [DOI] [PubMed] [Google Scholar]
  117. St Clair D., Norrman J., Perry R., Yates C., Wilcock G., Brookes A. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett. 1994 Jul 18;176(1):45–46. doi: 10.1016/0304-3940(94)90867-2. [DOI] [PubMed] [Google Scholar]
  118. Stern Y., Tang M. X., Denaro J., Mayeux R. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol. 1995 May;37(5):590–595. doi: 10.1002/ana.410370508. [DOI] [PubMed] [Google Scholar]
  119. Strittmatter W. J., Roses A. D. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4725–4727. doi: 10.1073/pnas.92.11.4725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Tournier-Lasserve E., Joutel A., Melki J., Weissenbach J., Lathrop G. M., Chabriat H., Mas J. L., Cabanis E. A., Baudrimont M., Maciazek J. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993 Mar;3(3):256–259. doi: 10.1038/ng0393-256. [DOI] [PubMed] [Google Scholar]
  122. Van Duijn C. M., Clayton D. G., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A. Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genet Epidemiol. 1994;11(6):539–551. doi: 10.1002/gepi.1370110609. [DOI] [PubMed] [Google Scholar]
  123. Verny M., Duyckaerts C., Pierot L., Hauw J. J. Leuko-araiosis. Dev Neurosci. 1991;13(4-5):245–250. doi: 10.1159/000112168. [DOI] [PubMed] [Google Scholar]
  124. Wilson A. L., Langley L. K., Monley J., Bauer T., Rottunda S., McFalls E., Kovera C., McCarten J. R. Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):509–514. doi: 10.1016/0091-3057(95)00043-v. [DOI] [PubMed] [Google Scholar]
  125. Yatham L. N., McHale P. A., Kinsella A. Down's syndrome and its association with Alzheimer's disease. Acta Psychiatr Scand. 1988 Jan;77(1):38–41. doi: 10.1111/j.1600-0447.1988.tb05074.x. [DOI] [PubMed] [Google Scholar]
  126. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995 Jun;45(6):1161–1168. doi: 10.1212/wnl.45.6.1161. [DOI] [PubMed] [Google Scholar]
  127. Zapatero M. D., Garcia de Jalon A., Pascual F., Calvo M. L., Escanero J., Marro A. Serum aluminum levels in Alzheimer's disease and other senile dementias. Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):235–240. doi: 10.1007/BF02790122. [DOI] [PubMed] [Google Scholar]
  128. de Vos R. A., Jansen E. N., Stam F. C., Ravid R., Swaab D. F. 'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg. 1995 Feb;97(1):13–22. doi: 10.1016/0303-8467(94)00060-j. [DOI] [PubMed] [Google Scholar]
  129. van Dijk P. T., Dippel D. W., Habbema J. D. Survival of patients with dementia. J Am Geriatr Soc. 1991 Jun;39(6):603–610. doi: 10.1111/j.1532-5415.1991.tb03602.x. [DOI] [PubMed] [Google Scholar]
  130. van Duijn C. M., Clayton D., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol. 1991;20 (Suppl 2):S13–S20. doi: 10.1093/ije/20.supplement_2.s13. [DOI] [PubMed] [Google Scholar]
  131. van Duijn C. M., Havekes L. M., Van Broeckhoven C., de Knijff P., Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ. 1995 Mar 11;310(6980):627–631. doi: 10.1136/bmj.310.6980.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. van Duijn C. M., de Knijff P., Cruts M., Wehnert A., Havekes L. M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994 May;7(1):74–78. doi: 10.1038/ng0594-74. [DOI] [PubMed] [Google Scholar]
  133. van Duijn C. M., de Knijff P., Wehnert A., De Voecht J., Bronzova J. B., Havekes L. M., Hofman A., Van Broeckhoven C. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol. 1995 May;37(5):605–610. doi: 10.1002/ana.410370510. [DOI] [PubMed] [Google Scholar]
  134. van Gool W. A., Evenhuis H. M., van Duijn C. M. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing. Ann Neurol. 1995 Aug;38(2):225–230. doi: 10.1002/ana.410380215. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES